EUVIMEDEUVIMED entdecken
CrossrefInfokarte

High screening coverage and positivity rates of HIV, syphilis, and hepatitis B among pregnant women accessing antenatal care in Sierra Leone

M.A. Sesay, B.D. Fofanah, D. Nair, A. Ramsay, N. Sesay, M.S. Kapuwa, I.F. Kamara, M. Sillah-Kanu, I.S. Turay, M. Mustapha, A.M. Falama, W.K. Lahai, F. Kanu, J.A. Koroma, G.N. Kamara, F. Thomas, S. Batcho, S. Lakoh

Public Health Action · 2026-08 · 16 (3) · 135-140

DOI: 10.5588/pha.25.0051 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Sierra Leone faces high rates of mother-to-child transmission (MTCT) of HIV, syphilis, and presumed hepatitis B (HepB). Since 2014, integrated testing and treatment within antenatal care (ANC) have aimed to prevent this transmission, yet no comprehensive study on these infections among pregnant women exists. OBJECTIVES Assess screening coverage and test positivity for these infections in 21 health facilities in 4 districts, each representing Sierra Leone’s four regions, to ensure national representation of triple elimination testing: Primary (12), Secondary (5), and Tertiary (4). METHOD A cross-sectional analysis of secondary data from health-facility registers in Western Area Urban, Bombali, Bo, and Kenema districts, between November 2024 and October 2025, summarised as frequencies and proportions. RESULTS Among 10,003 women attending their first ANC visit, screening coverage was 99.6% for HIV, 99.6% for syphilis, 92.9% for HepB, and 92.4% for all three infections. Test positivity was 4.9% for HIV, 1.3% for syphilis, and 4.0% for HepB. CONCLUSION Triple-disease testing at ANC facilities in Sierra Leone is feasible and can achieve high coverage. The test-positivity rate for HepB suggests a considerable burden of maternal infection and ongoing MTCT. Still, there are currently no interventions to address this gap. Testing should be scaled-up urgently and followed by a programme for maternal treatment, safe delivery, and immunisation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →